Supporting Resilience Among Re-entered Seniors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age45+
SponsorUniversity of Louisville

About this trial

The first goal (Aim 1) of this clinical trial is to learn about specific strengths, challenges, and desired areas of knowledge and skill-building among older adults who re-entered their communities from a period of incarceration and to then develop a new psychoeducational intervention tailored to these older adults. The second goal (Aim 2) of this clinical trial is to test if the intervention increases chronic disease management and whether the intervention is considered appropriate and acceptable by older adults who re-entered their communities from a period of incarceration.

Aim 1 participants will:

* complete a baseline survey * participate in a focus group

Aim 2 participants will:

* complete a baseline survey * participate in an 8-week once weekly intervention * complete three follow up surveys

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

at least 45 years old

have re-entered the community from a period of incarceration from jail or prison

have at least one chronic health condition

able to speak and understand English

Disqualifiers

aged 44 or younger

have not re-entered the community from a period of incarceration from jail or prison

does not have at least one chronic health condition

unable to speak and understand English

Trial design

Design model

Single group

Treatments tested in this trial

  • Psychoeducation

    Behavioral

    Psychoeducation is the therapeutic management of illness through the increase of related knowledge, skills, and motivation.

Treatment groups

8 Participants
are divided into 1 treatment group
Group A: Supporting resilience psychoeducational groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Chronic disease self managment

Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Chronic Conditions measures (viz. daily activities, medications and treatments, symptoms, emotions, social interactions)

Time frame
12 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Louisville

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator